SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Suven to present positive Preclinical, Phase-1 clinical data of advanced molecules at Sleep 2018

01 Jun 2018 Evaluate

Suven Life Sciences (Suven) will participate and present positive Preclinical and Phase-1 clinical data of advanced molecules from their portfolio of new chemical entities (NCEs) at Sleep 2018, A Joint Meeting of The American Academy of Sleep Medicine and The Sleep Research Society being held at Baltimore, MD, USA during June 2-6, 2018.

SLEEP is the premier world forum to present and discuss the latest developments in clinical sleep medicine and sleep and circadian science.

The SLEEP meeting provides evidence-based education to advance the science and clinical practice of sleep medicine, disseminates cutting-edge sleep and circadian research, promotes the translation of basic science into clinical practice.

During the conference Suven will present their Phase 2 ready differentiated Clinical stage therapeutic candidate SUVN-G3031 (Histamine-3 receptor antagonist) for the treatment of Narcolepsy and Narcolepsy associated with Cataplexy. Narcolepsy is a commercially attractive space with a large unmet need. The data presentation highlight Suven’s continued commitment to explore new treatment options addressing unmet medical need through novel mechanisms and targets.


Suven Life Sciences Share Price

276.00 8.75 (3.27%)
29-Jun-2026 15:18 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1874.60
Dr. Reddys Labs. 1375.00
Cipla 1455.40
Zydus Lifesciences 1121.00
Lupin 2416.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: